Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Geary

Showing results (51-60 of 152) with videos related to

Pageof 16
Sort By:
Analytical Biochemistry|April 24, 2002
Development of an ultrasensitive noncompetitive hybridization-ligation enzyme-linked immunosorbent assay for the determination of phosphorothioate oligodeoxynucleotide in plasmaRosie Z Yu, Brenda Baker, Alfred Chappell, et al.
Nucleic Acid Therapeutics|July 9, 2021
Improvements in the Tolerability Profile of 2'-<i>O</i>-Methoxyethyl Chimeric Antisense Oligonucleotides in Parallel with Advances in Design, Screening, and Other MethodsWesley Partridge, Shuting Xia, T Jesse Kwoh, et al.
Nucleic Acids Research|September 25, 1992
Rapid mini-preparations of total RNA from bacteriaT Barry, S Geary, S Hannify, et al.
Journal of Neuroendocrinology|February 13, 2009
Triiodothyronine regulates insulin-like growth factor-I binding to cultured rat pituitary cellsE S Geary, M Lim, G P Ceda, et al.
Antisense & Nucleic Acid Drug Development|March 22, 2000
Absorption of antisense oligonucleotides in rat intestine: effect of chemistry and lengthO Khatsenko, R Morgan, L Truong, et al.
Nucleic Acid Therapeutics|August 12, 2017
Lack of QT Prolongation for 2'-O-Methoxyethyl-Modified Antisense Oligonucleotides Based on Retrospective Exposure/Response Analysis of Ten Phase 1 Dose-Escalation Placebo-Controlled Studies in Healthy SubjectsRosie Z Yu, Rudy Gunawan, Richard S Geary, et al.
Journal of Medicinal Chemistry|October 1, 1985
Synthesis and biological activity of certain 6-substituted and 2,6-disubstituted 2'-deoxytubercidins prepared via the stereospecific sodium salt glycosylation procedureH B Cottam, Z Kazimierczuk, S Geary, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 19, 2006
Cross-species pharmacokinetic comparison from mouse to man of a second-generation antisense oligonucleotide, ISIS 301012, targeting human apolipoprotein B-100Rosie Z Yu, Tae-Won Kim, An Hong, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 27, 1999
Preclinical evaluation of the effects of a novel antisense compound targeting C-raf kinase in mice and monkeysD K Monteith, R S Geary, J M Leeds, et al.
Radiation Research|February 1, 1989
The disposition of ethiofos (WR-2721) in the isolated perfused rat liverM D Coleman, L Fleckenstein, R S Geary, et al.
Pageof 16

Showing results (51-60 of 152) with videos related to

Sort By:
Pageof 16
Analytical Biochemistry|April 24, 2002
Development of an ultrasensitive noncompetitive hybridization-ligation enzyme-linked immunosorbent assay for the determination of phosphorothioate oligodeoxynucleotide in plasmaRosie Z Yu, Brenda Baker, Alfred Chappell, et al.
Nucleic Acid Therapeutics|July 9, 2021
Improvements in the Tolerability Profile of 2'-<i>O</i>-Methoxyethyl Chimeric Antisense Oligonucleotides in Parallel with Advances in Design, Screening, and Other MethodsWesley Partridge, Shuting Xia, T Jesse Kwoh, et al.
Nucleic Acids Research|September 25, 1992
Rapid mini-preparations of total RNA from bacteriaT Barry, S Geary, S Hannify, et al.
Journal of Neuroendocrinology|February 13, 2009
Triiodothyronine regulates insulin-like growth factor-I binding to cultured rat pituitary cellsE S Geary, M Lim, G P Ceda, et al.
Antisense & Nucleic Acid Drug Development|March 22, 2000
Absorption of antisense oligonucleotides in rat intestine: effect of chemistry and lengthO Khatsenko, R Morgan, L Truong, et al.
Nucleic Acid Therapeutics|August 12, 2017
Lack of QT Prolongation for 2'-O-Methoxyethyl-Modified Antisense Oligonucleotides Based on Retrospective Exposure/Response Analysis of Ten Phase 1 Dose-Escalation Placebo-Controlled Studies in Healthy SubjectsRosie Z Yu, Rudy Gunawan, Richard S Geary, et al.
Journal of Medicinal Chemistry|October 1, 1985
Synthesis and biological activity of certain 6-substituted and 2,6-disubstituted 2'-deoxytubercidins prepared via the stereospecific sodium salt glycosylation procedureH B Cottam, Z Kazimierczuk, S Geary, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 19, 2006
Cross-species pharmacokinetic comparison from mouse to man of a second-generation antisense oligonucleotide, ISIS 301012, targeting human apolipoprotein B-100Rosie Z Yu, Tae-Won Kim, An Hong, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 27, 1999
Preclinical evaluation of the effects of a novel antisense compound targeting C-raf kinase in mice and monkeysD K Monteith, R S Geary, J M Leeds, et al.
Radiation Research|February 1, 1989
The disposition of ethiofos (WR-2721) in the isolated perfused rat liverM D Coleman, L Fleckenstein, R S Geary, et al.
Pageof 16